M Karen J Gagnon

Title: M Karen J Gagnon: Innovator in Radiopharmaceuticals

Introduction

M Karen J Gagnon is a notable inventor based in Moose Jaw, Canada. She has made significant contributions to the field of radiopharmaceuticals, holding two patents that showcase her innovative work. Her research focuses on enhancing the purity and efficiency of radiopharmaceutical compounds.

Latest Patents

Gagnon's latest patents include a groundbreaking invention related to prosthetic groups attached to stannyl polymer in the synthesis of radiopharmaceuticals. This invention provides compositions and methods for preparing radiopharmaceutical compounds with high chemical and isotopic purity. The polymer-bound precursors can be converted to radiopharmaceutical compounds in a single step. A key feature of this invention is the use of a prosthetic group comprising an alkenyl-tin bond, which allows for the efficient conversion of the precursor into the final radiopharmaceutical compound. The toxic tin by-product can be easily removed from the compound through filtration, making the process safer and more efficient. This invention is versatile, allowing for the installation of various radioisotopes, including At, I, or I.

Career Highlights

Gagnon is affiliated with the University of Western Ontario, where she continues her research and development in the field of radiopharmaceuticals. Her work has garnered attention for its potential applications in medical imaging and treatment.

Collaborations

One of her notable collaborators is Duncan H Hunter, with whom she has worked on various projects related to her patents.

Conclusion

M Karen J Gagnon's contributions to the field of radiopharmaceuticals highlight her innovative spirit and dedication to advancing medical technology. Her patents reflect a commitment to improving the safety and efficacy of radiopharmaceutical compounds.